THE LONG-TERM IMPACT OF BEDAQUILINE-CONTAINING REGIMENS ON COST BURDEN OF DRUG-RESISTANT TUBERCULOSIS IN INDIA

被引：0
|
作者：
Agnarson, M. A. [1 ]
Potluri, R. [2 ]
Bhandari, H. [3 ]
Dhir, A. [4 ]
Kumar, A. [3 ]
Gupta, V [5 ]
Raute, L. [5 ]
Shah, N. [5 ]
Kambili, C. [6 ]
Metz, L. [1 ]
机构：
[1] Johnson & Johnson, New Brunswick, NJ USA
[2] SmartAnalyst Inc, New York, NY USA
[3] SmartAnalyst India Pvt Ltd, Gurgaon, India
[4] SmartAnalyst India Pvt Ltd, Gurgaon, HR, India
[5] Janssen India, Mumbai, Maharashtra, India
[6] Johnson & Johnson, South Raritan, NJ USA
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PIN48
引用
收藏
页码：S648 / S648
页数：1
相关论文
共 50 条
  • [21] Safety of Bedaquiline-Containing Regimens in Patients with Pulmonary Multidrug-Resistant Tuberculosis and HIV Co-Infection
    Villa, G. Castillo
    Padayatchi, N.
    Bionghi, N.
    Osman, F.
    Naidu, N.
    Master, I.
    Naidoo, K.
    Ramjee, A.
    O'Donnell, M. R.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [22] Clinical Outcomes Among Patients With Drug-resistant Tuberculosis Receiving Bedaquiline- or Delamanid-Containing Regimens
    Kempker, R. R.
    Mikiashvili, L.
    Zhao, Y.
    Benkeser, D.
    Barbakadze, K.
    Bablishvili, N.
    Avaliani, Z.
    Peloquin, C. A.
    Blumberg, H. M.
    Kipiani, M.
    [J]. CLINICAL INFECTIOUS DISEASES, 2020, 71 (09) : 2336 - 2344
  • [23] Early efficacy of individual regimens containing bedaquiline in patients with drug resistant tuberculosis
    Putra, Oki Nugraha
    Yulistiani, Yulistiani
    Soedarsono, Soedarsono
    Subay, Susi
    [J]. ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE, 2023, 16 (04) : 169 - 175
  • [24] Early efficacy of individual regimens containing bedaquiline in patients with drug resistant tuberculosis
    Oki Nugraha Putra
    Yulistiani Yulistiani
    Soedarsono Soedarsono
    Susi Subay
    [J]. Asian Pacific Journal of Tropical Medicine, 2023, (04) : 169 - 175
  • [25] Cardiac safety of extensively drug-resistant tuberculosis regimens including bedaquiline, delamanid and clofazimine
    Wallis, Robert S.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2016, 48 (05) : 1526 - 1527
  • [26] Compassionate use of bedaquiline in highly drug-resistant tuberculosis patients in Mumbai, India
    Udwadia, Zarir F.
    Ganatra, Shashank
    Mullerpattan, Jai B.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2017, 49 (03)
  • [27] Long-term bedaquiline-related treatment outcomes in patients with extensively drug-resistant tuberculosis from South Africa
    Olayanju, Olatunde
    Limberis, Jason
    Esmail, Aliasgar
    Oelofse, Suzette
    Gina, Phindile
    Pietersen, Elize
    Fadul, Mohammed
    Warren, Rob
    Dheda, Keertan
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2018, 51 (05)
  • [28] Efficacy and safety of bedaquiline containing regimens in patients of drug-resistant tuberculosis: An updated systematic review and meta-analysis
    Rehman, Obaid Ur
    Fatima, Eeshal
    Ali, Abraish
    Akram, Umar
    Nashwan, Abdulqadir
    Yunus, Faryal
    [J]. JOURNAL OF CLINICAL TUBERCULOSIS AND OTHER MYCOBACTERIAL DISEASES, 2024, 34
  • [29] Bedaquiline containing triple combination powder for inhalation to treat drug-resistant tuberculosis
    Rangnekar, Bhamini
    Momin, Mohammad A. M.
    Eedara, Basanth Babu
    Sinha, Shubhra
    Das, Shyamal C.
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2019, 570
  • [30] Establishing the Safety and Efficacy of Bedaquiline-Containing Regimen for the Treatment of Drug-Resistant Tuberculosis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
    Jihwaprani, Muhammad Candragupta
    Sun, Yipeng
    Rizky, Wahyu Choirur
    Sula, Idris
    Saquib, Nazmus
    [J]. PULMONARY MEDICINE, 2024, 2024
12345